Bronchodilators
Opening the airways — beta-2 agonists and antimuscarinics, and asthma versus COPD.
Asthma vs COPD: One Reverses, One Doesn't
Asthma and COPD both cause breathlessness, wheeze and cough from narrowed airways — yet they are fundamentally different diseases, and one single distinction drives almost all of their treatment. Get that distinction clear and you'll instantly understand why steroids are central to one and bronchodilators to the other.
Beta-2 Agonists: The Blue Inhaler That Opens the Airway
The blue reliever inhaler that millions of people carry is a beta-2 agonist — and it's a perfect payoff from the autonomic nervous system chapter. It relaxes airway muscle by triggering the same 'fight or flight' receptor that widens your airways when you run. Understanding that one receptor explains how the drug works, why it comes in fast and slow versions, and where its side effects come from.
Antimuscarinic Bronchodilators: Opening the Airway the Other Way
There are two ways to relax airway muscle: switch on the 'open' signal, or switch off the 'close' signal. Beta-2 agonists do the first; antimuscarinics do the second — by blocking the parasympathetic nerve that keeps airways tight. They're a second pillar of bronchodilation, especially important in COPD, and another direct payoff from the autonomic chapter.
